Literature DB >> 15790090

Sacral resection and reconstruction for tumors and tumor-like conditions.

R Lor Randall1, James Bruckner, Chris Lloyd, Timothy H Pohlman, Ernest U Conrad.   

Abstract

Sacrectomy is intended to resect aggressive local and life-threatening disease. Reconstruction can be difficult. This article reports on the use of sacrectomy for tumor and tumor-like conditions. Procedures included 9 partial, 7 subtotal, 7 hemi-, and 4 total sacrectomies. Of 22 patients with primary malignant disease, 64% were alive without evidence of disease. The local recurrence rate was 27%. Thirty-two percent developed metastatic disease and 32% died from progressive disease. The complication rate was 33%. Tumor control was achieved in 73%. Postoperative complications occurred in 33%. Sacral resection remains a challenging operation.

Entities:  

Mesh:

Year:  2005        PMID: 15790090     DOI: 10.3928/0147-7447-20050301-17

Source DB:  PubMed          Journal:  Orthopedics        ISSN: 0147-7447            Impact factor:   1.390


  16 in total

1.  CORR Insights(®): Sacral Insufficiency Fractures are Common after High-dose Radiation for Sacral Chordomas Treated With or Without Surgery.

Authors:  Joshua C Patt
Journal:  Clin Orthop Relat Res       Date:  2015-10-30       Impact factor: 4.176

2.  High long-term local control with sacrectomy for primary high-grade bone sarcoma in children.

Authors:  Alexandre Arkader; Christine H Yang; Vernon T Tolo
Journal:  Clin Orthop Relat Res       Date:  2011-12-03       Impact factor: 4.176

3.  Surgical classification of different types of en bloc resection for primary malignant sacral tumors.

Authors:  Dasen Li; Wei Guo; Xiaodong Tang; Tao Ji; Yidan Zhang
Journal:  Eur Spine J       Date:  2011-06-29       Impact factor: 3.134

4.  Slug signaling is up-regulated by CCL21/CCR7 [corrected] to induce EMT in human chondrosarcoma.

Authors:  Guosong Li; Yanjun Yang; Siliang Xu; Lifeng Ma; Mingtang He; Ziqing Zhang
Journal:  Med Oncol       Date:  2015-01-03       Impact factor: 3.064

5.  SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway.

Authors:  Peng Yang; Gang Wang; Hongjun Huo; Qiang Li; Yan Zhao; Yuanhang Liu
Journal:  Med Oncol       Date:  2014-11-27       Impact factor: 3.064

6.  Surgical margins and local control in resection of sacral chordomas.

Authors:  Pietro Ruggieri; Andrea Angelini; Giuseppe Ussia; Maurizio Montalti; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

7.  What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?

Authors:  Tao Ji; Wei Guo; Rongli Yang; Xiaodong Tang; Yifei Wang; Lin Huang
Journal:  Clin Orthop Relat Res       Date:  2017-03       Impact factor: 4.176

8.  Transsacral colon fistula: late complication after resection, irradiation and free flap transfer of sacral chondrosarcoma.

Authors:  Lars Steinstraesser; Michael Sand; Stefan Langer; Gert Muhr; Thomas A Schildhauer; Hans-Ulrich Steinau
Journal:  World J Surg Oncol       Date:  2008-11-11       Impact factor: 2.754

9.  Surgical management of chordoma: A systematic review.

Authors:  Luca Denaro; Alessandra Berton; Mauro Ciuffreda; Mattia Loppini; Vincenzo Candela; Maria Luisa Brandi; Umile Giuseppe Longo
Journal:  J Spinal Cord Med       Date:  2018-07-26       Impact factor: 1.985

10.  Imaging appearances and clinical outcome following sacrectomy and ilio-lumbar reconstruction for sacral neoplasia.

Authors:  Marianna Thomas; A M Davies; A J Stirling; R J Grimer; M Grainger; Steven L J James
Journal:  Skeletal Radiol       Date:  2013-11-17       Impact factor: 2.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.